1. Volume 14, Issue 4, Pages 499-505 (June 2011)
Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System 
J. Félix, MSc, V. Andreozzi, PhD, M. Soares, MSc, P. Borrego, Pharm D, H. Gervásio, MD, A. Moreira, MD, L. Costa, PhD, F. Marcelo, MD, F. Peralta, MD, I. Furtado, F. Pina, PhD, C. Albuquerque, MD, A. Santos, MD, J.L. Passos-Coelho, MD 
Value in Health 
Volume 14, Issue 4, Pages (June 2011)
DOI: /j.jval
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Data Collection Scheme. Patients eligible for inclusion had undergone treatment for ≥ 1 skeletal-related event (SRE) in the 12 months prior to study entry. Resource utilization during these 12 months was used to determine the cost of treating SREs.
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Mean Treatment Cost by SRE Type. Mean cost of treatment for each type of skeletal-related event (SRE) was determined using hospital records of direct treatment-costs (excluding chemo/hormonal therapy for cancer and patient-reported costs).
Value in Health  , DOI: ( /j.jval )
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions